Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1976 Sep;10(3):457-61.
doi: 10.1128/AAC.10.3.457.

Pharmacokinetics of cefamandole in patients undergoing hemodialysis and peritoneal dialysis

Pharmacokinetics of cefamandole in patients undergoing hemodialysis and peritoneal dialysis

M J Ahern et al. Antimicrob Agents Chemother. 1976 Sep.

Abstract

The pharmacokinetics of cefamandole nafate, a new parenteral cephalosporin derivative, were evaluated in 11 patients with chronic renal failure (creatinine clearance less than 5 ml/min), including five patients during hemodialysis, four patients during routine peritoneal dialysis, and two patients during the interdialytic period. Peak serum levels of cefamandole were comparable to those observed in patients with normal renal function. Clearance of the drug during the interdialytic period and during hemodialysis and peritoneal dialysis was minimal, with a resultant significant prolongation of serum half-life. The nondialyzability of cefamandole is in contrast with reported studies of cephalothin, where significant reduction of the serum half-life was achieved during hemodialysis but not peritoneal dialysis. The concentration of cefamandole in the peritoneal dialysate after parenteral administration was observed to be bactericidal for many gram-negative pathogens and, with the exception of Streptococcus faecalis, most gram-positive organisms found in bacterial peritonitis in patients with severe renal failure. The present data suggest that if stable bactericidal serum levels of cefamandole are to be maintained during hemodialysis and peritoneal dialysis, a parenteral loading dose must be administered followed by one-half the loading dose every half-life.

PubMed Disclaimer

Similar articles

Cited by

References

    1. N Engl J Med. 1966 Mar 24;274(12):654-6 - PubMed
    1. Antimicrob Agents Chemother. 1974 Aug;6(2):177-82 - PubMed
    1. J Clin Invest. 1959 Sep;38:1487-97 - PubMed
    1. N Engl J Med. 1958 Nov 20;259(21):999-1005 - PubMed
    1. Postgrad Med J. 1970 Oct;:Suppl:57-9 - PubMed

LinkOut - more resources